Sign up to save your podcasts
Or
Share October 2024: Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective Disorder
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
October 2024: Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective Disorder
Dr. Bodyl Brand (Oxford University, UK) joins AJP Audio to discuss the effectiveness of menopausal hormone therapy in preventing psychosis relapse in women with schizophrenia and schizoaffective disorder. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin takes us through the rest of the October issue of the American Journal of Psychiatry, which focuses on other issues touching psychosis and schizophrenia spectrum disorders.
- 01:05 Brand interview
- 03:08 MHT and potential side effects in schizophrenia treatment
- 06:16 Estrogen and psychosis prophylaxis
- 07:44 MHT effectiveness
- 10:15 Clinical implications
- 11:27 Strengths and limitations
- 13:47 The need for further study
- 15:54 Further research
- 17:24 Kalin interview
- 17:47 Brand et al.
- 20:17 Partanen et al.
- 23:54 Moran et al.
- 26:48 Gallucci et al.
- 30:38 Arion et al.
Transcript
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
How authors may submit their work.
Follow the journals of APA Publishing on Twitter.
E-mail us at [email protected]
View all episodes
By American Journal of Psychiatry
3.9
7373 ratings
Dr. Bodyl Brand (Oxford University, UK) joins AJP Audio to discuss the effectiveness of menopausal hormone therapy in preventing psychosis relapse in women with schizophrenia and schizoaffective disorder. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin takes us through the rest of the October issue of the American Journal of Psychiatry, which focuses on other issues touching psychosis and schizophrenia spectrum disorders.
- 01:05 Brand interview
- 03:08 MHT and potential side effects in schizophrenia treatment
- 06:16 Estrogen and psychosis prophylaxis
- 07:44 MHT effectiveness
- 10:15 Clinical implications
- 11:27 Strengths and limitations
- 13:47 The need for further study
- 15:54 Further research
- 17:24 Kalin interview
- 17:47 Brand et al.
- 20:17 Partanen et al.
- 23:54 Moran et al.
- 26:48 Gallucci et al.
- 30:38 Arion et al.
Transcript
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
How authors may submit their work.
Follow the journals of APA Publishing on Twitter.
E-mail us at [email protected]
More shows like American Journal of Psychiatry Audio
View all
Neurology® Podcast
280 Listeners
Medicine and Science from The BMJ
38 Listeners
NEI Podcast
136 Listeners
Speaking of Psychology
65 Listeners
Core EM - Emergency Medicine Podcast
248 Listeners
JAMA Clinical Reviews
478 Listeners
The Curbsiders Internal Medicine Podcast
3,317 Listeners
JAMA Psychiatry Author Interviews
22 Listeners
Psychiatry & Psychotherapy Podcast
1,301 Listeners
Psychopharmacology and Psychiatry Updates
291 Listeners
Psychoanalysis On and Off the Couch
147 Listeners
The Carlat Psychiatry Podcast
560 Listeners
Back from the Abyss: Psychiatry in Stories
443 Listeners
The Curbsiders Addiction Medicine Podcast
117 Listeners
PsychRounds: The Psychiatry Podcast
103 Listeners